All Things Urticaria

By Global Allergy and Asthma Excellence Network - UCARE in collaboration with MedthorityScience

All Things Urticaria episodes

November 06, 2023 Episode 74 - Non-steroidal anti-inflammatory drugs in CSU
Professor Riccardo Asero joins Professor Marcus Maurer to offer advice on the use of non-steroidal anti-inflammatory drugs (NSAID) in people with chronic spontaneous urticaria (CSU). The experts discuss risk assessment and strategies to avoid respiratory and cutaneous hypersensitivity reactions in people who require these common medications to manage comorbidities.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: Nonsteroidal anti-inflammatory drugs hypersensitivity in chronic spontaneous urticaria in the light of its pathogenesis and Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.
Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
24 min
October 23, 2023 Episode 73 - Urticaria and stress
Professor Marcus Maurer is joined by Professor Eduardo Souza Lima to explore the relationship between stress and urticaria, and the implications of mast cells and neuropeptides in chronic spontaneous urticaria.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: Neuro-Immuno-Psychological Aspects of Chronic Urticaria, Expression of Hypothalamic-Pituitary-Adrenal Axis in Common Skin Diseases: Evidence of its Association with Stress-related Disease Activity, Psychological Stress and Chronic Urticaria: A Neuro-immuno-cutaneous Crosstalk. A Systematic Review of the Existing Evidence, Exaggerated Neurophysiological Responses to Stressor in Patients with Chronic Spontaneous Urticaria, Disease Activity and Stress are Linked in a Subpopulation of Chronic Spontaneous Urticaria Patients and High Prevalence of Mental Disorders and Emotional Distress Patients with Chronic Spontaneous Urticaria.
Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
23 min
October 06, 2023 Episode 72 - IL-9, IL-10 and CSU pathogenesis
Dermatologist Professor Kiran Godse joins Professor Marcus Maurer to explore the use of JAK and STAT inhibitors in the management of chronic urticaria and how these drugs may impact quality of life for people with this condition.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: Role of IL-9 and IL-10 in the pathogenesis of chronic spontaneous urticaria through the JAK/STAT signalling pathway and Efficacy of Oral Ruxolitinib in a Patient with Refractory Chronic Spontaneous Urticaria.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
19 min
September 22, 2023 Episode 71 - The patient perspective
Professor Marcus Maurer is joined by the president of Global Allergy & Airways Patient Platform (GAAPP), Tonya Winders, for a special Urticaria Day (UDAY) episode to discuss the role patient advocacy groups play in supporting individuals with chronic spontaneous urticaria. Both experts explore patient unmet needs and highlight methods clinicians can use to help overcome these barriers.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external link to access additional resources relating to the topics discussed in this episode: Global Allergy & Airways Patient Platform.
Access additional resources by signing up to Medthorityand to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
25 min
September 14, 2023 Episode 70 - Urticaria management in resource-poor settings
Dr Désirée Larenas-Linnemann and Professor Marcus Maurer delve into best practices for urticaria management in resource-poor settings, underlining the crucial role of accurate diagnosis and adherence to established guidelines. They also address trending topics in angioedema and urticaria treatment, such as antihistamine up-dosing and the complexities surrounding triple-combination therapies and the need for better education.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here:
Utilise the following external links to access additional resources relating to the topics discussed in this episode: Mexican Guide to the Diagnosis and Treatment of Urticaria | Allergy Magazine Mexico (revistaalergia.mx), https://ga2len-ucare.com/Urticaria Control Test (Survey), Urticaria.net, Urticaria Test Selection and the MOXIE Website
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
21 min
August 24, 2023 Episode 69 - The burdens of angioedema
Professor Marcus Maurer is joined by Professor Paula Busse to explore the multifaceted burdens of angioedema for patients and physicians. They discuss issues surrounding timely diagnosis, interpreting ambiguous symptoms, patient concerns about medications, and enhancing quality of life monitoring.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema, The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update and the CARE Registry.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
25 min
August 11, 2023 Episode 68 - Angioedema and CSU
Dr Régis de Albuquerque Campos joins Professor Marcus Maurer to discuss the implications of angioedema and its impact on people living with chronic spontaneous urticaria (CSU). Dr Campos highlights diverse aspects of the burden of CSU and the impact misdiagnosis has on quality of life. Professor Maurer provides an overview of the current treatment landscape, differential diagnosis, unmet needs in angioedema clinical trials and the utilisation of omalizumab in managing angioedema associated with CSU.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department, Isolated angioedema: A review of classification and update on management and The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
24 min
July 27, 2023 Episode 67 - Angioedema and artificial intelligence
Professor Markus Magerl joins Professor Marcus Maurer in this episode to explore the significance of differential diagnosis in the identification of angioedema in chronic spontaneous urticaria (CSU). Professor Magerl takes a deep dive into the prospective use of artificial intelligence (AI) in the analysis of data derived from a questionnaire utilising algorithmic models. Both professors, Maurer and Magerl, discuss the implications AI can have in enhancing the diagnostic accuracy of angioedema.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: 10 Questions - Using AI for diagnosing your or your patient´s angioedema, Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin‑Mediated vs. Mast Cell–Mediated Angioedema and Case Report: Recurrent Angioedema: Diagnosing the Rare and the Frequent.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
22 min
July 17, 2023 Episode 66 - Urticaria and the CRUSE app
Professor Marcus Maurer is joined by Dr Aistė Ramanauskaitė to explore the CRUSE app's potential advantages for individuals suffering from chronic spontaneous urticaria. Professor Maurer emphasises the importance and utilisation of the CRUSE app, while Dr. Ramanauskaitė delves into the various benefits and practical applications offered by the app.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external link to access additional resources relating to the topics discussed in this episode: UCARE YouTube Channel.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
27 min
July 03, 2023 Episode 65 - Audience proposed question: Guidance for potential treatments of CSU
Professor Martin Metz joins Professor Marcus Maurer to answer an audience proposed question focusing on what will guide physicians in the recommendations for individual patients to identify the most beneficial treatment option to treat chronic spontaneous and inducible urticaria. Both experts delve into the current treatment options available, and exciting treatments that are currently in clinical trials.
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Utilise the following external links to access additional resources relating to the topics discussed in this episode: Dupilumab in CSU, Remibrutinib in CSU, Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune-mediated dermatological conditions, An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria, Barzolvolimab in mast cell depletion, Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances, Chronic urticaria and the pathogenic role of mast cells and Urticaria (an overview).
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.
26 min

About All Things Urticaria

From the publisher's feed

Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry.